The Management of Persistent or Recurrent Variceal Bleeding After Injection Sclerotherapy by Somatostatin
1992

Managing Variceal Bleeding with Somatostatin

Sample size: 16 publication Evidence: moderate

Author Information

Author(s): S.A. Jenkins, R. Shields, N. Jaser, S. Ellenbogen, E. Naylor, J.N. Baxter

Primary Institution: University Department of Surgery, Royal Liverpool University Hospital

Hypothesis

Is somatostatin effective in controlling persistent or recurrent variceal bleeding after injection sclerotherapy?

Conclusion

Somatostatin infusion is an effective treatment for controlling variceal bleeding after failed injection sclerotherapy.

Supporting Evidence

  • Somatostatin controlled bleeding in 15 of the 16 patients.
  • One patient rebled after 72 hours of treatment.
  • Bleeding was not controlled in one patient with severe liver dysfunction.

Takeaway

Doctors used a medicine called somatostatin to help stop bleeding in patients with swollen veins in their throat, and it worked for most of them.

Methodology

Patients with persistent or recurrent variceal bleeding were treated with an intravenous infusion of somatostatin.

Limitations

The study was uncontrolled and had a small sample size.

Participant Demographics

16 patients (11 males, 5 females) with a median age of 56.5 years.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication